Status:
COMPLETED
Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein
Lead Sponsor:
Sohag University
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
6-18 years
Phase:
PHASE4
Brief Summary
The current management of type 1 diabetes mellitus (T1DM) depends on the use of intensive insulin therapy - either by insulin pump therapy or multiple daily injection (MDI) therapy - and the use of ca...
Detailed Description
The study will include children and adolescents aged 6 - 18 years, diagnosed with T1DM for at least 1 year, using multiple daily injection regimen and carbohydrate counting. The study participants wil...
Eligibility Criteria
Inclusion
- Children and adolescents aged 6 - 18 years
- diagnosed with T1DM for at least 1 year
- using MDI regimen with advanced carbohydrate counting for at least 6 months
Exclusion
- Subjects with associated
- diabetic autonomic neuropathy
- hypothyroidism
- celiac disease.
Key Trial Info
Start Date :
April 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 3 2022
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04783376
Start Date
April 12 2021
End Date
March 3 2022
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sawsana Ewieda
Sohag, Egypt